Metraipolis › archive › dc_fc5e5af2ea62
Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41788614
- DOI
- 10.1093/ckj/sfaf373
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T03:47:39.904Z
- SHA-256 of the archived text
5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba- Stable URL of this page
https://metraipolis.com/documento/dc_fc5e5af2ea62
How to cite
Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614 — Europe PMC (en), https://europepmc.org/article/MED/41788614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc5e5af2ea62 (Metraipolis archive dc_fc5e5af2ea62, sha256 5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba)
BibTeX
@misc{dcfc5e5af2ea62,
title = {Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41788614},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc5e5af2ea62; sha256 5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41788614. Agents can read the archived copy with the MCP tool read_document.